XBB.1.5 RBD-Based Bivalent Vaccines Induced Antibody Responses Against SARS-CoV-2 Variants in Mice
(1) Background: The currently circulating variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits resistance to antibodies induced by vaccines. The World Health Organization recommended the use of monovalent XBB.1 sublineages (e.g., XBB.1.5) as an antigenic component in 2023...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2025-05-01
|
| Col·lecció: | Vaccines |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2076-393X/13/5/543 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|